Showing results (11-20 of 119) with videos related to
Sort By:
Pageof 12
Pharmacology & Therapeutics|December 3, 2014
Deubiquitinase inhibition as a cancer therapeutic strategyPadraig D'Arcy, Xin Wang, Stig LinderJournal of Proteome Research|August 9, 2005
Clinical cancer proteomics: promises and pitfallsAyodele Alaiya, Mai Al-Mohanna, Stig LinderCancer Metastasis Reviews|November 15, 2017
Proteasome-associated deubiquitinases and cancerArjan Mofers, Paola Pellegrini, Stig Linder, et al.Urologic Oncology|January 5, 2025
Development of point-of-care tests for urinary bladder cancer - an historic review and view to future prospectivesThorsten H Ecke, Johan Styrke, Kiran Jagarlamudi, et al.Expert Review of Molecular Diagnostics|April 8, 2010
Utilization of cytokeratin-based biomarkers for pharmacodynamic studiesStig Linder, Maria Hägg Olofsson, Richard Herrmann, et al.The Journal of Biological Chemistry|January 2, 2003
Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signalingAleksandra Mandic, Johan Hansson, Stig Linder, et al.Journal of Chemical Biology|July 2, 2009
Conditional drug screening shows that mitotic inhibitors induce AKT/PKB-insensitive apoptosisMaria Berndtsson, Emma Hernlund, Maria C Shoshan, et al.International Journal of Molecular Sciences|May 5, 2021
Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the OvariesXiaonan Zhang, Mihir Shetty, Valentino Clemente, et al.Cancer Letters|August 28, 2004
Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarkerStig Linder, Aleksandra Mandic Havelka, Takayuki Ueno, et al.Molecular Biosystems|June 23, 2010
Chemical biology suggests a role for calcium signaling in mediating sustained JNK activation during apoptosisSlavica Brnjic, Maria Hägg Olofsson, Aleksandra Mandic Havelka, et al.Pageof 12